Impact of COVID-19 on cancer research funding
Cancer Research UK has announced that the impact of COVID-19 on its income means it could be forced to cut £150m per year from...
ABPI Code consultation – Have your say
The ABPI is launching a public consultation on the proposed 2021 ABPI Code of Practice for the pharmaceutical industry. Pharmaceutical companies, patient organisations, NHS...
MSD announces results for investigational 15-valent pneumococcal conjugate vaccine
MSD has announced results from two initial Phase 3 studies evaluating the safety, tolerability and immunogenicity of V114, the company’s investigational 15-valent pneumococcal conjugate...
New consortium to monitor safety and effectiveness of COVID-19 vaccines
A new consortium to monitor the safety and effectiveness of COVID-19 vaccines has been formed by the Drug Safety Research Unit (DSRU) in Southampton...
Support for developers of COVID-19 medicinal products
The National Institute for Health and Care Excellence (NICE) and the National Institute for Health Research (NIHR) have launched a guide on clinical evidence...
First human trials of Imperial College COVID-19 vaccine to start
Clinical researchers are to begin the first human trials of a new COVID-19 vaccine developed by Imperial College London with support from the NIHR. Many...
Lilly begins Phase 3 clinical trial of Baricitinib as a COVID-19 treatment
Lilly begins a Phase 3 clinical trial with Baricitinib as a COVID-19 treatment for hospitalised COVID-19 patients. The study will further understanding of Baricitinib’s...
Medicines regulations need democratic oversight says National Pharmacy Association
In a formal submission to MPs, the National Pharmacy Association argues that changes to regulations on medicines supply should be subject to parliamentary scrutiny,...
Dexamethasone shown to improve COVID-19 survival
Low-cost dexamethasone has been shown to improve COVID-19 survival by reducing death by up to one third in hospitalised patients with severe respiratory complications...
NHS and Microsoft 365 deal to join-up health service
An agreement struck between NHSX, NHS Digital and Microsoft will save the NHS hundreds of millions of pounds and enable all eligible organisations in...
Latest articles
Becoming a leading pharma company in the new normal
The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...
Innovative technology in the medical devices market
Bernard Ross explores innovative technology in the medical devices market especially relating to venous thromboembolism (VTE). According to Cordant Recruitment, the global medical devices market...
COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Innovative technology in the medical devices market
Bernard Ross explores innovative technology in the medical devices market especially relating to venous thromboembolism (VTE). According to Cordant Recruitment, the global medical devices market...
Becoming a leading pharma company in the new normal
The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...
Market Access in practice: do you have a strategy?
This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...